Document is current
Any future updates will be listed below
-
Authors
Trauzeddel, R. F.
Leitner, M.
Dehé, L.
Nordine, M.
Piper, S. K.
Habicher, M.
Sander, M.
Perka, C.
Treskatsch, S.
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 21 March 2023
First Online: 6 April 2023
Declarations
:
: All procedures involving humans were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments. The original study, as well as the amendment, was approved by the local ethics committee at Charité–Universitätsmedizin Berlin (EA 1/315/12, Chairperson Dr. R. Uebelhack) (date of approval of the original study 05.12.2021, date of approval of the amendment 04.10.2014). Informed written consent was obtained from all study patients in the prospective part.
: Not applicable.
: RFT, ML, LD, MN, SKP and CP have nothing to declare. MH received payment from Edwards Lifesciences and AMOMED due to lecturing activities. MS received financial activities from Edwards Lifesciences, Medtronic, the Getinge Group, FERRER, AMOMED, Orion Pharma, Grünenthal, Fisher & Paykel, BTG and Ratiopharm. ST received funding for experimental research as well as honoraria for lectures from Edwards, OrionPharma, Amomed and Smith & Nephews outside this work.
